BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BAT5906 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BAT5906\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07515079-4969@assetmemo.bio
DTSTAMP:20261121T004024Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:BAT5906: Phase 3 readout est. (NCT07515079)
DESCRIPTION:BAT5906\, phase 3.\nStudy: Efficacy Evaluation Study of BAT5906
  and Lucentis® in Patients With Diabetic Macular Edema\nEstimated primary
  completion: 30 April 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/bat5906#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07515079
URL:https://assetmemo.bio/drug/bat5906#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
